Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Adicet Bio Inc
(NQ:
ACET
)
1.490
-0.050 (-3.25%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
471,514
Open
1.540
Bid (Size)
1.500 (3)
Ask (Size)
1.550 (7)
Prev. Close
1.540
Today's Range
1.490 - 1.570
52wk Range
1.050 - 3.770
Shares Outstanding
42,957,586
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Adicet Bio Appoints Lloyd Klickstein, M.D., Ph.D. to the Board of Directors
August 19, 2024
From
Adicet Bio, Inc.
Via
Business Wire
ACET Stock Earnings: Adicet Bio Beats EPS for Q2 2024
August 13, 2024
ACET stock results show that Adicet Bio beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Performance
YTD
-25.87%
-25.87%
1 Month
-1.32%
-1.32%
3 Month
-4.49%
-4.49%
6 Month
-38.43%
-38.43%
1 Year
-10.78%
-10.78%
More News
Read More
Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
August 13, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in Upcoming Investor Conferences
August 01, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio: Q4 Earnings Insights
March 19, 2024
Via
Benzinga
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
July 31, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
July 08, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
June 28, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces FDA Clearance of IND Application for ADI-270 in Renal Cell Carcinoma
June 24, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Under-$10 Picks: 3 Biotech Stocks That Can Double Before the End of 2024
June 10, 2024
Via
InvestorPlace
Adicet Bio Receives FDA Fast Track Designation for ADI-001 in Lupus Nephritis
June 05, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
May 31, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the 2024 Jefferies Healthcare Conference
May 29, 2024
From
Adicet Bio, Inc.
Via
Business Wire
ACET Stock Earnings: Adicet Bio Beats EPS for Q1 2024
May 14, 2024
Via
InvestorPlace
Adicet Reports First Quarter 2024 Financial Results and Provides Business Updates
May 14, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Announces Poster Presentation of ADI-270 Preclinical Data at the 2024 European Hematology Association (EHA) Hybrid Congress
May 14, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the Citizens JMP Life Sciences Conference
May 07, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
April 30, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
April 22, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference
April 08, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
March 28, 2024
From
Adicet Bio, Inc.
Via
Business Wire
The Penny Stock A-List: 7 High-Profile Companies on the Verge of Greatness
March 28, 2024
Via
InvestorPlace
ACET Stock Earnings: Adicet Bio Meets EPS for Q4 2023
March 19, 2024
Via
InvestorPlace
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress
March 19, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
March 11, 2024
From
Adicet Bio, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.